G+FLAS said it provides CRISPR-related research services, tools, and reagents and applies CRISPR technology to develop drugs and produce genome-edited plants.
The method could be used to determine the function of thousands of mutations to see whether they cause disease, or confer drug sensitivity or resistance.
The gift from philanthropists Allen and Charlotte Ginsburg will support a new center within UCLA's Institute for Precision Health and a patient clinic.
Researchers used CRISPR to reintroduce an archaic variant of NOVA1 into cortical organoids to study how a human-specific variant may have affected evolution.
This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.
